Get Started

ATRA

NASD Atara Biotherapeutics Inc
Oct 25, 2026 · 2:49 PM ET EOD Market Closed

$8.59 ↑ +0.00 (+0.00%) Trading Up from the previous close of $8.59, $0.78 below the day’s high of $9.37

YTD change
-52.52%
vs 20-day SMA
-6.06%
vs 200-day SMA
+11.12%

Price ranges

Previous day
$8.55 $9.37
open $9.37 close $8.59
-$0.78 (-8.32%)
Today
$8.55 $9.37
$8.59
Past week
$8.88 $9.91
from $9.65 now $8.59
-$1.06 (-10.98%)
Past month
$7.83 $9.99
from $8.54 now $8.59
+$0.05 (+0.59%)
This year
$3.92 $19.15
from $18.09 now $8.59
-$9.50 (-52.52%)

Price & Performance

+3.60 (+72.14%) / 6M

$4.04$6.76$9.49$12.21Apr 27Jul 27Oct 23

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Not So Good
  • The stock is 99.4% away from all-time highs of $1,361.25
  • ATRA is down 53% since the beginning of the year
  • ATRA is down 39% over the past 12 months
  • ATRA is up 1% over the past 1 month
  • 3% of all ATRA investors are betting against ATRA

ATRA reads not so good: price sits above one of the two key moving averages, the 12-month move is -44.9%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No
EPS $-0.32
Earnings momentum -141.0% Quarterly EPS growth
Quarterly change -141.0%

Valuation

P/E ratio N/A
Enterprise value $183.3M
Beta 0.60

Balance sheet & scale

IncomeN/A
Revenue$6.2M
Cash$9.9M
Debt$51.4K
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Sector Professional, Scientific, and Technical Services
Industry Group Scientific Research and Development Services
Market cap $86.2M

Atara Biotherapeutics, Inc. is an allogeneic T-cell immunotherapy company, which engages in the development of transformative therapies for patients with serious diseases including solid tumors, hematologic cancers, and autoimmune diseases. It also delivers off-the-shelf treatments to patients with high unmet medical need. Its product pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in Thousand Oaks, CA.

Competitor comparison

TickerCompany PriceChange
AMGN Amgen Inc. $439.26 -1.79%
MRNA Moderna, Inc. $200.10 -1.25%
RVMD Revolution Medicines, Inc. $186.99 -0.37%
ROIV Roivant Sciences Ltd. $36.49 -2.56%
BNTX BioNTech SE Sponsored ADR $88.12 -1.73%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.